Growth Metrics

Anaptysbio (ANAB) Cash from Operations (2016 - 2025)

Anaptysbio filings provide 10 years of Cash from Operations readings, the most recent being 97997000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 246.98% year-over-year to 97997000.0, compared with a TTM value of 19697000.0 through Dec 2025, up 114.55%, and an annual FY2025 reading of 19697000.0, up 114.55% over the prior year.
  • Cash from Operations hit 97997000.0 in Q4 2025 for Anaptysbio, up from 27356000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 97997000.0 in Q4 2025, with the low at 66672000.0 in Q4 2024.
  • Median Cash from Operations over the past 5 years was 23675500.0 (2021), compared with a mean of 17797650.0.
  • The sharpest move saw Cash from Operations plummeted 351.77% in 2022, then surged 246.98% in 2025.
  • Year by year, Cash from Operations stood at 25301000.0 in 2021, then soared by 57.77% to 10685000.0 in 2022, then crashed by 221.47% to 34349000.0 in 2023, then crashed by 94.1% to 66672000.0 in 2024, then skyrocketed by 246.98% to 97997000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 97997000.0, 27356000.0, and 40244000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.